Raffinazine Impurity C
|
雷芬那辛雜質(zhì)C
|
|
Raffinazine Impurity B
|
雷芬那辛雜質(zhì)B
|
|
2-HYDROXYBENZOIC ACID 4-(ACETYLAMINO)PHENYL ESTER
|
貝諾酯雜質(zhì)1
|
118-57-0
|
Benzoic acid, 2-(acetyloxy)-, 4-aminophenyl ester
|
貝諾酯雜質(zhì)2
|
63949-11-1
|
Dapagliflozin Impurity 178
|
達(dá)格列凈雜質(zhì)178
|
|
Moxifloxacin nitrosamine impurity 4
|
莫西沙星亞硝胺雜質(zhì)4
|
|
Moxifloxacin nitrosamine impurity 2
|
莫西沙星亞硝胺雜質(zhì)2
|
|
Moxifloxacin nitrosamine impurity 3
|
莫西沙星亞硝胺雜質(zhì)3
|
|
Pinaverium Bromide Impurity
|
匹維溴銨雜質(zhì)PVB-Z4
|
|
2-(chloromethyl)-2-methyl-1,3-Propanediol
|
2(氯甲基)-2-甲基丙烷-1,3-二醇
|
21139-44-6
|
Dapoxetine iMpurity
|
達(dá)泊西汀雜質(zhì)
|
94305-25-6
|
Flucloxacillin EP Impurity B
|
氟氯西林雜質(zhì)B
|
1276016-89-7
|
Doxapram N-Oxide
|
多沙普侖雜質(zhì)C
|
2724726-82-1
|
4-Dimethylaminopyridine
|
4-二甲氨基吡啶對照品
|
1122-58-3
|
Landiolol Impurity
|
"((S)-2,2-二甲基-1,3-二氧戊環(huán)-4-基)甲基3- (4-(((S)-環(huán)氧乙烷-2-基)甲氧基)苯基)丙酸酯"
|
|
4-Formyl-3-methoxybenzamide
|
非奈利酮雜質(zhì)A-4
|
1289153-30-5
|
4-formyl-3-methoxybenzoic acid
|
非奈利酮雜質(zhì)A-5
|
80893-99-8
|
4-Cyano-2-Methoxybenzoic acid
|
非奈利酮雜質(zhì)A-6
|
89469-52-3
|
4-Amino-2-hydroxy-5-methylpyridine
|
非奈利酮雜質(zhì)Z2-2
|
95306-64-2
|
2-chloro-5-Methyl-4-nitropyridine
|
非奈利酮雜質(zhì)C-5
|
97944-45-1
|
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate
|
非奈利酮雜質(zhì)Z3-1
|
1050477-43-4
|
4,4'-(1,2-Diphenylethene-1,2-diyl)diphenol
|
他莫昔芬雜質(zhì)8
|
68578-79-0
|
2,2'-Binaphthalene-6,6'-dicarboxylic Acid
|
阿達(dá)帕林雜質(zhì)A
|
932033-58-4
|
Canagliflozin Impurity 8
|
達(dá)格列凈雜質(zhì)8
|
1807632-93-4
|
Cefradine EP Impurity G
|
頭孢拉定雜質(zhì)G
|
146794-70-9
|
ALLURA RED
|
誘惑紅
|
25956-17-6
|
Finerenone Impurity 10
|
非奈利酮雜質(zhì)10
|
2640280-83-5
|
Dapoxetine impurity
|
鹽酸達(dá)泊西汀雜質(zhì)
|
2242008-38-2
|
Finerenone Impurity 17
|
非奈利酮雜質(zhì)17
|
2640280-82-4
|
Finerenone Impurity 8
|
非奈利酮雜質(zhì)8
|
2087452-81-9
|
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
|
非奈利酮雜質(zhì)1
|
1050477-45-6
|
3-acetylphenyl ethyl(methyl)carbamate
|
重酒石酸卡巴拉汀雜質(zhì)D
|
855300-09-3
|
3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate hydrochloride
|
重酒石酸卡巴拉汀雜質(zhì)B
|
105601-13-6
|
Upadacitinib
|
烏帕替尼
|
1310726-60-3
|
1-MONOBUTYRIN
|
丁酸甘油酯
|
557-25-5
|
(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl acetate
|
右蘭索拉唑雜質(zhì)6
|
112525-75-4
|
Lansoprazole Sulfone N-Oxide
|
右蘭索拉唑雜質(zhì)G
|
953787-54-7
|
2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole
|
右蘭索拉唑雜質(zhì)T
|
103312-62-5
|
N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole Sulfide
|
右蘭索拉唑雜質(zhì)R
|
1083100-27-9
|
3-hydroxy-Octanedioic acid
|
3-羥基辛二酸
|
73141-47-6
|
Lys-Lys dihydrochloride
|
L-賴氨酰-L-賴氨酸二鹽酸鹽
|
52123-30-5
|
Valsartan Related Compound A
|
纈沙坦USP雜質(zhì)A
|
137862-87-4
|
Dapagliflozin Impurity 68
|
達(dá)格列凈雜質(zhì)68
|
1404477-10-6
|
Ethyl 3-anilinobut-2-enoate
|
3-(苯基氨基)-2-丁烯酸乙酯
|
6287-35-0
|
2,4-Dichlorophenylacetic acid
|
2,4-二氯苯乙酸
|
19719-28-9
|
Vildagliptin Impurity C
|
維格列汀雜質(zhì)C
|
565453-40-9
|
2-(chloromethyl)-3-methylpyridin-4-ol
|
右蘭索拉唑雜質(zhì)U
|
1805648-51-4
|
8-HYDROXY-3,4-DIHYDRO-2-QUINOLINONE
|
8-羥基-3,4-二氫-2-喹啉酮
|
52749-50-5
|
6-Hydroxy-2(1H)-3,4-dihydroquinolinone
|
3,4-二氫-6-羥基-2(1H)-喹啉酮
|
54197-66-9
|
(R)-4-Propyldihydrofuran-2(3H)-one
|
布瓦西坦中間體1
|
63095-51-2
|
(3S,4R)-3-ethyl-4-(6-ethyl-6,9a-dihydro-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
|
(3S,4R)-3-乙基-4-(6-乙基-6,9a-二氫-3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪-8-基)-N- (2,2,2-三氟乙基)吡咯烷-1-甲酰胺
|
|
benzyl (3R,4S)-3-(N-(tert-butoxycarbonyl)-N-(5-tosyl-5H- pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate
|
芐基(3R,4S)-3-(N-(叔丁氧基羰基)-N-(5-甲苯磺?;?5H-吡咯并[2,3-b]吡嗪-2-基)甘氨酰)-4-乙基吡咯烷-1-羧酸鹽
|
1428243-27-9
|
(4-Chloro-2-nitro-phenyl)-acetic acid
|
4-氯-2-硝基苯乙酸
|
37777-71-2
|
Iminodiacetic acid
|
亞氨基二乙酸
|
142-73-4
|
Glycyl-glycyl-glycine
|
甘氨酸EP雜質(zhì)I
|
556-33-2
|
DL-ALPHA-AMINO-EPSILON-CAPROLACTAM
|
賴氨匹林EP雜質(zhì)D
|
671-42-1
|
Glycylglycine
|
甘氨酸EP雜質(zhì)H
|
556-50-3
|
Nitroglycerin solution EP impurity B
|
硝化甘油溶液EP雜質(zhì)B
|
624-43-1
|
Nalpha-Acetyl-D-asparagine
|
N2-乙酰-D-天冬酰胺
|
26117-27-1
|
Ezetimibe Impurity O
|
依折麥布雜質(zhì)O
|
1798008-25-9
|
6-amino-5-formamido-1,3-dimethyluracil
|
茶堿雜質(zhì)C
|
7597-60-6
|
3-Hydroxy-4-Methyl-2(5H)-thiophenone
|
3-羥基-4-甲基噻吩酮
|
34876-35-2
|
2-METHYL-N-(PHENYLMETHYLENE)-2-PROPYLAMINE
|
N-二甲氨基芐叔丁胺
|
6852-58-0
|
Acetylcysteine EP Impurity D
|
乙酰半胱氨酸EP雜質(zhì)D
|
18725-37-6
|
GLYCINE ANHYDRIDE
|
甘氨酸EP雜質(zhì)B
|
106-57-0
|
DeoxyBenzoinOxime
|
三苯乙酮肟
|
952-06-7
|
(S,S)-2,8-Diazabicyclo[4,3,0]nonane
|
莫西沙星雜質(zhì)72
|
151213-40-0
|
2-Hydroxyethylhydrazine
|
2-羥乙基肼
|
109-84-2
|
Salbutamol Impurity E
|
沙丁胺醇雜質(zhì)E
|
24085-03-8
|
3-Amino-2-oxazolidinone
|
3-氨基-2-噁唑烷酮
|
80-65-9
|
N-tert-butyldibenzylamine
|
N,N-二芐基叔丁胺
|
30923-82-1
|
2'-(Methylthio)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one
|
2-(甲硫基)-7,8-二氫-6H-螺[環(huán)己烷-1,9-吡嗪并[1,2:1,5]吡咯并[2,3-d]嘧啶]-6酮
|
2170747-00-7
|
10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine
|
培拉嗪
|
84-97-9
|
Tamoxifen Impurity 2
|
他莫昔芬雜質(zhì)2
|
123091-15-6
|
Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-, 1,1-dimethylethyl ester
|
曲拉西利雜質(zhì)23
|
2170746-99-1
|
1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)cyclopropanecarboxylic acid
|
萊伯雷生中間體6雜質(zhì)對照品
|
1369769-35-6
|
(1S,2R)-1-(3-Fluorophenyl)-2-(hydroxymethyl)cyclopropanecarbonitrile
|
(1S,2R)-1-(3-氟苯基)-2-(羥甲基)環(huán)丙烷-1-腈
|
1450904-98-9
|
(1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate
|
萊伯雷生中間體3雜質(zhì)
|
1369768-29-5
|
2'-(Methylsulfonyl)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one
|
2-(甲基磺?;?-7,8-二氫-6H-螺[環(huán)己烷-1,9-吡嗪并[1,2:1,5]吡咯并[2,3-d]嘧啶]-6酮
|
2170747-01-8
|
ethyl 2-(methylthio)-4-(3-oxo-1,4-diazaspiro[5.5]undecan-1-yl)pyrimidine-5-carboxylate
|
2-(甲硫基)-4-(3-氧代-1,4-二氮雜螺[5.5]十一烷-1-基)嘧啶-5-羧酸乙酯
|
2170746-95-7
|
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
|
R-亞砜
|
160552-54-5
|
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox
|
混合二聚體
|
1093279-77-6
|
Paroxetine Impurity 5
|
左旋帕羅醇非對映異構(gòu)體
|
100332-20-5
|
ent-Paroxol
|
右旋帕羅醇
|
389573-45-9
|
Mono-POC Tenofovir
|
替諾福韋單酯
|
211364-69-1
|
Mono-POC Isopropyl Tenofovir
|
替諾福韋異丙基單吡呋酯
|
1422284-15-8
|
Lenalidomide Impurity 22
|
來那度胺雜質(zhì)22
|
2717380-87-3
|
Piperacillin Impurity J
|
哌拉西林雜質(zhì)J
|
|
4-CHLORO-3,5-DIAMINOBENZOIC ACID
|
3,5-二氨基-4-氯苯甲酸
|
69236-82-4
|
Rivastigmine Related Compound G
|
重酒石酸卡巴拉汀雜質(zhì)G
|
|
Benzenemethanol, 2-(hydroxyamino)-
|
[2-(羥基氨基)苯基]甲醇
|
41882-63-7
|
benzyl (3S,4R)-3-(2-chloroacetyl)-4-ethylpyrrolidine-2-carboxylate
|
(3S,4R)-3-(2-氯乙?;?-4-乙基吡咯烷-1-甲酸芐酯
|
2304514-69-8
|
Esmolol Hydrochloride impurity 2
|
艾司洛爾雜質(zhì)
|
116144-60-6
|
1,3-bis(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)urea
|
1,3-雙(5-甲苯磺?;?5H-吡咯并[2,3-b]吡嗪-2-基)脲
|
|
Lemborexant Impurity 6
|
(1S,2R)-2-(((2,4-二甲基嘧啶-5-基)氧基)甲基)-1-(3-氟苯基)-N-(5-氟吡啶-2-基)環(huán)丙烷-1-甲酰胺
|
2541020-19-1
|
Daunorubicin EP Impurity B
|
柔紅霉素EP雜質(zhì)B
|
|
benzyl (3S,4R)-3-ethyl-4-(2-(methylsulfinyl)acetyl)pyrrolidine -1-carboxylate
|
(3R,4S)-3-(2-(二甲基(氧代)-λ6-磺酰亞基)乙?;?4-乙基吡咯烷-1-羧酸芐酯
|
|
benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
|
(3R,4R)-3-(2-溴乙?;?-4-乙基-1-吡咯烷羧酸芐酯
|
2304514-60-9
|
5-tosyl-5H-pyrrolo[2,3-b]pyrazine
|
5-甲苯磺酰基-5H-吡咯并[2,3-b]吡嗪
|
1944483-53-7
|
(±)-Rivaroxaban
|
利伐沙班消旋體
|
482306-32-1
|